Back
Nanoparticle Paclitaxel (Nanoxel) as a Safe and Cost-Effective Radio-Sensitizer in Locally Advanced Head and Neck Carcinoma
Akshay Nigam, Anupama Sharma, Sanjeev Kumar Singh
J. Cancer Ther. Vol.3 No.1, February 16, 2012  DOI: 10.4236/jct.2012.31006
       (PDF  56K)     HTML     
Long Term Progression Free Survival Achieved by Maintenance “Second–Line” Polychemotherapy with Gemcitabine/Paclitaxel in Metastatic Urothelial Cancer of the Renal Pelvis—A Case Report
Andreas Bannowsky, Hermann Ahlen, Klaus-Peter Jünemann
J. Cancer Ther. Vol.1 No.4, December 31, 2010  DOI: 10.4236/jct.2010.14035
       (PDF  444K)     HTML     
Chemotherapy (Gemcitabine plus Carboplatin versus Paclitaxel plus Carboplatin) in Elderly Patients with Non-Small Cell Lung Cancer
Takanori Ayabe, Masaki Tomita, Eiichi Chosa, Makoto Ikenoue, Yukie Shirasaki, Kunihide Nakamura
J. Cancer Ther. Vol.5 No.3, March 25, 2014  DOI: 10.4236/jct.2014.53035
       (PDF  400K)     HTML     
Triplet chemotherapy with paclitaxel, gemcitabine, and cisplatin as second-line therapy for advanced urothelial carcinoma
Hideki Takeshita, Koji Chiba, Sachi Kitayama, Shingo Moriyama, Rika Omura, Akira Noro
Mod. Chemother. Vol.2 No.1, January 30, 2013  DOI: 10.4236/mc.2013.21001
       (PDF  503K)     HTML      XML
Chemotherapy Induced Amenorrhea in Women Treated with Chemotherapy for Breast Carcinoma in Yalgado Ouédraogo Teaching Hospital in Ouagadougou, Burkina Faso
Augustin Tozoula Bambara, Hyacinthe Zamané, Yobi Alexis Sawadogo, Hierrhum Aboubacar Bambara, Awa Mien, Nayi Zongo, Abdoul Azize Diallo, Ali Ouédraogo, Si Simon Traoré
Open J. Obstet. Gynecol. Vol.7 No.1, January 18, 2017  DOI: 10.4236/ojog.2017.71014
       (PDF  285K)     HTML      XML
 
 
Top